Middle East & Africa RNAi Technology Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Regional

Share This On

Home > Reports > Biotechnology > Agriculture > Middle East & Africa RNAi Technology Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Chapter 1 Introduction

    1.1 Executive Summary

    1.2 Market Definition

    1.3 Scope of the Study

Chapter 2 Research Methodology

    2.1 Secondary Research

    2.2 Primary Research

    2.3 Analytic Tools and Model

    2.4 Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5 Expert Validation

    2.6 Study Timeline

Chapter 3 Market Analysis

    3.1 Industry Value Chain Analysis

    3.2Porter's Five Force Analysis

            3.2.1 Bargaining Power of Buyers

            3.2.2 Bargaining Power of Suppliers

            3.2.3 Threats of Substitutes

            3.2.4 Threats of New Entrants

            3.2.5 Industry Rivalry

    3.3 PESTLE Analysis

            3.3.1 Political

            3.3.2 Economical

            3.3.3 Social

            3.3.4 Technological

            3.3.5 Legal

            3.3.6 Environmental

    3.4 SWOT Analysis

            3.4.1 Strengths

            3.4.2 Weakness

            3.4.3 Opportunities

            3.4.4 Threats

    3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

    4.1. Drivers

            4.1.1 Increasing research activities in RNAi technology mainly in cancer

    4.2. Restraints

            4.2.1 FDA regulations and reimbursement facilities

    4.3 Opportunities

            4.3.1 Rising demand for genetics-based on In-Vitro-Diagnostics

    4.4 Challenges

            4.4.1 Determining design for siRNA sequence and off-target effects.

Chapter 5 Middle East & Africa RNAi Technology Market - By Application

    5.1 Agriculture

    5.2 Research and development

    5.3 Drug discovery

    5.4 Therapeutics

            5.4.1 Autoimmune Hepatitis

            5.4.2 Ocular Disorders

            5.4.3 Hepatitis B and C

            5.4.4 Oncology

            5.4.5 Respiratory Disorders

            5.4.6 Heart ailments

            5.4.7 Neurodegenerative disease

            5.4.8 Others

Chapter 6 Middle East & Africa RNAi Technology Market - By Geography

    6.1 Introduction

    6.2. Middle East & Africa

            6.2.1.  The Middle East

            6.2.2. Africa

Chapter 7 Middle East & Africa RNAi Technology Market - Company Profiles

    7.1. Arcturus Therapeutics

    7.2. Benitec Biopharma Ltd

    7.3. Alnylam Pharmaceuticals

    7.4. Takara Bio Inc. (Clonetch)

    7.5. Quark Pharmaceuticals Inc.

    7.6. Ionis Pharmaceuticals Inc.

    7.7. Invitrogen.

    7.8. Silence Therapeutics

    7.9. Qiagen NV

    7.10. Thermo Fisher Scientific Inc.

    7.11 Merck & Co. Inc. (Sigma Aldrich)

    7.12 Pfizer Inc.

    7.13 F. Hoffmann-La Roche Ag (Roche)

Chapter 8 Middle East & Africa RNAi Technology Market - Competitive Landscape

    8.1. Market Share Analysis

    8.2. Strategies Adopted by top companies

    8.3. Mergers, Acquisitions, Collaborations & Agreements

Chapter 9 Market Insights

    9.1. Industry Experts Insights

    9.2. Analysts Opinions

    9.3. Investment Opportunities

Chapter 10 Appendix

    10.1 List of Tables

    10.2 List of Figures

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion